Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery
|
November 19, 2009
[Analysis of clinical characteristics of gastrointestinal cancer in Heilongjiang province, China 1998 to 2007]
Xiao-ming Zou, Xi-shan Wang, Yun-long Li, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 27, 2007
Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis
Wenqing Yao, Jincong Zhuo, David M Burns, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 22, 2008
Structure-activity relationships of anthranilamide-based factor Xa inhibitors containing piperidinone and pyridinone P4 moieties
James R Corte, Tianan Fang, Donald J P Pinto, et al.
Plos One
|
June 22, 2018
Preclinical characterization of INCB053914, a novel pan-PIM kinase inhibitor, alone and in combination with anticancer agents, in models of hematologic malignancies
Holly Koblish, Yun-Long Li, Niu Shin, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 10, 2022
Discovery of 1'-(1-phenylcyclopropane-carbonyl)-3H-spiro[isobenzofuran-1,3'-pyrrolidin]-3-one as a novel steroid mimetic scaffold for the potent and tissue-specific inhibition of 11β-HSD1 using a scaffold-hopping approach
Colin Zhang, Meizhong Xu, Chunhong He, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 12, 2017
INCB040093 Is a Novel PI3K<i>δ</i> Inhibitor for the Treatment of B Cell Lymphoid Malignancies
Niu Shin, Yun-Long Li, Song Mei, et al.
Journal of Medicinal Chemistry
|
May 27, 2026
Discovery of the Orally Bioavailable Isoform Selective Janus Kinase 1 (JAK1) Compound Povorcitinib (INCB054707) for the Treatment of Inflammatory and Autoimmune Diseases
Jincong Zhuo, Yun-Long Li, Ding-Quan Qian, et al.
ACS Medicinal Chemistry Letters
|
November 22, 2019
INCB050465 (Parsaclisib), a Novel Next-Generation Inhibitor of Phosphoinositide 3-Kinase Delta (PI3Kδ)
Eddy W Yue, Yun-Long Li, Brent Douty, et al.
Cancer Biology & Therapy
|
April 22, 2006
Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cells
Phillip C C Liu, Xiangdong Liu, Yanlong Li, et al.
Journal of Medicinal Chemistry
|
January 30, 2007
Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancer
Wenqing Yao, Jincong Zhuo, David M Burns, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery
|
November 19, 2009
[Analysis of clinical characteristics of gastrointestinal cancer in Heilongjiang province, China 1998 to 2007]
Xiao-ming Zou, Xi-shan Wang, Yun-long Li, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 27, 2007
Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis
Wenqing Yao, Jincong Zhuo, David M Burns, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 22, 2008
Structure-activity relationships of anthranilamide-based factor Xa inhibitors containing piperidinone and pyridinone P4 moieties
James R Corte, Tianan Fang, Donald J P Pinto, et al.
Plos One
|
June 22, 2018
Preclinical characterization of INCB053914, a novel pan-PIM kinase inhibitor, alone and in combination with anticancer agents, in models of hematologic malignancies
Holly Koblish, Yun-Long Li, Niu Shin, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 10, 2022
Discovery of 1'-(1-phenylcyclopropane-carbonyl)-3H-spiro[isobenzofuran-1,3'-pyrrolidin]-3-one as a novel steroid mimetic scaffold for the potent and tissue-specific inhibition of 11β-HSD1 using a scaffold-hopping approach
Colin Zhang, Meizhong Xu, Chunhong He, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 12, 2017
INCB040093 Is a Novel PI3K<i>δ</i> Inhibitor for the Treatment of B Cell Lymphoid Malignancies
Niu Shin, Yun-Long Li, Song Mei, et al.
Journal of Medicinal Chemistry
|
May 27, 2026
Discovery of the Orally Bioavailable Isoform Selective Janus Kinase 1 (JAK1) Compound Povorcitinib (INCB054707) for the Treatment of Inflammatory and Autoimmune Diseases
Jincong Zhuo, Yun-Long Li, Ding-Quan Qian, et al.
ACS Medicinal Chemistry Letters
|
November 22, 2019
INCB050465 (Parsaclisib), a Novel Next-Generation Inhibitor of Phosphoinositide 3-Kinase Delta (PI3Kδ)
Eddy W Yue, Yun-Long Li, Brent Douty, et al.
Cancer Biology & Therapy
|
April 22, 2006
Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cells
Phillip C C Liu, Xiangdong Liu, Yanlong Li, et al.
Journal of Medicinal Chemistry
|
January 30, 2007
Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancer
Wenqing Yao, Jincong Zhuo, David M Burns, et al.
Page
of 7